{"id": "eipxnr", "title": "Good time to get on $BLUE", "selftext": "It's the beginning of the year and things are looking good for gene therapy overall.\n\nEspecially good for bluebird bio. They have an affordable price plan for life threatening diseases and had an early success in Europe. FDA also said they would be approving \" between 10 and 20 gene and cell therapies per year by 2025. \" \n\n&amp;#x200B;\n\n&amp;#x200B;\n\nOver the 5 days, $BLUE hit its 52-wk high of $95 and fell back down to 87.75 which makes it a good entry-point for you autists.\n\nTo add on top of this, there are going to be TWO presentations just this month\n\n&gt;Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View  from the Top, Thursday, January 9, at 2:00 p.m. ET at the Goldman Sachs  Offices, New York City   \n&gt;  \n&gt;38th Annual J.P. Morgan Healthcare Conference, Tuesday,  January 14, at 3:00 p.m. PT at the Westin St. Francis Hotel, San  Francisco, followed by a question and answer breakout session at 3:30  p.m. \n\nIf you want to play risky, go for Jan 17 $100 calls but if you wanna play safe go with May 15th $120.", "created_utc": 1577922814, "permalink": "/r/wallstreetbets/comments/eipxnr/good_time_to_get_on_blue/", "is_self": true}